When exploring tumor-infiltrating lymphocytes (TILs) after radiotherapy in patients with prostate cancer, researchers observed a higher number of CCR7+ TILs in tumor biopsies post-radiotherapy (78). The gene discussed is CCR7; the disease is neoplasm.